The effect of parthenolide on methamphetamine-induced blood-brain barrier and astrocyte alterations.
astrocytes
blood-brain barrier
methamphetamine
neuroinflammation
parthenolide
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
23
09
2021
received:
21
07
2021
accepted:
11
10
2021
pubmed:
26
10
2021
medline:
18
3
2022
entrez:
25
10
2021
Statut:
ppublish
Résumé
Methamphetamine abuse is a worldwide concern with long-term health complications. Its impact on neurons has been extensively investigated, and it is currently known that glial cells, including astrocytes, are involved in drug-induced outcomes. Importantly, METH also causes blood-brain barrier (BBB) disruption and astrocytes are critical for BBB (dys)function. Therefore, we aimed to clarify the involvement of neuroinflammation mediated by astrocytes in BBB permeability and brain oedema induced by METH. Further, we aimed to identify a new approach to counteract METH effects. Mice were administered with a METH binge regimen (4 × 10 mg/kg) alone or in combination with parthenolide (PTL; 4 × 1 mg/kg), and hippocampi were analysed. For in vitro studies, mouse primary cultures of astrocytes were exposed to 250 µM METH, alone or co-treated with 10 µM PTL. We observed a neuroinflammatory response characterized by astrocytic morphological changes and increased TNF-α, iNOS and ICAM-1 protein levels (213.62%, 205.76% and 191.47% of control, respectively). Additionally, brain oedema and BBB disruption were identified by increased water content (81.30% of tissue weight) and albumin (224.40% of control) in the hippocampal tissue, as well as a significant decrease in vessel coverage by astrocytes after METH exposure. Regarding astrocyte cultures, we further identified TNF-α as a key player in METH-induced cell swelling. Importantly, PTL (present in feverfew plant) prevented both animal and in vitro effects induced by METH. We provided important insights on brain dysfunction induced by METH, and we also suggest a new approach to counteract such negative effects.
Sections du résumé
BACKGROUND
BACKGROUND
Methamphetamine abuse is a worldwide concern with long-term health complications. Its impact on neurons has been extensively investigated, and it is currently known that glial cells, including astrocytes, are involved in drug-induced outcomes. Importantly, METH also causes blood-brain barrier (BBB) disruption and astrocytes are critical for BBB (dys)function. Therefore, we aimed to clarify the involvement of neuroinflammation mediated by astrocytes in BBB permeability and brain oedema induced by METH. Further, we aimed to identify a new approach to counteract METH effects.
METHODS
METHODS
Mice were administered with a METH binge regimen (4 × 10 mg/kg) alone or in combination with parthenolide (PTL; 4 × 1 mg/kg), and hippocampi were analysed. For in vitro studies, mouse primary cultures of astrocytes were exposed to 250 µM METH, alone or co-treated with 10 µM PTL.
RESULTS
RESULTS
We observed a neuroinflammatory response characterized by astrocytic morphological changes and increased TNF-α, iNOS and ICAM-1 protein levels (213.62%, 205.76% and 191.47% of control, respectively). Additionally, brain oedema and BBB disruption were identified by increased water content (81.30% of tissue weight) and albumin (224.40% of control) in the hippocampal tissue, as well as a significant decrease in vessel coverage by astrocytes after METH exposure. Regarding astrocyte cultures, we further identified TNF-α as a key player in METH-induced cell swelling. Importantly, PTL (present in feverfew plant) prevented both animal and in vitro effects induced by METH.
CONCLUSIONS
CONCLUSIONS
We provided important insights on brain dysfunction induced by METH, and we also suggest a new approach to counteract such negative effects.
Substances chimiques
Sesquiterpenes
0
parthenolide
2RDB26I5ZB
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13694Informations de copyright
© 2021 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
UNODC (2020) World Drug Report 2020. United Nations publication, Sales No. E.20.XI.6.
Leitão RA , Coelho-Santos V , Silva AP . Methamphetamine and the blood-brain barrier. In: Preedy VR , ed. Neuropathology of Drug Addictions and Substance Misuse. Vol. 2, Part 1: Stimulants. Academic Press-Elsevier; 2016:155-168.
Gonçalves J , Baptista S , Martins T , et al. Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci. 2010;31:2.
Leitão RA , Sereno J , Castelhano JM , et al. Aquaporin-4 as a new target against methamphetamine-induced brain alterations: focus on the neurogliovascular unit and motivational behavior. Mol Neurobiol. 2018;55:3.
Coelho-Santos V , Leitao RA , Cardoso FL , et al. The TNF-alpha/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction. J Cereb Blood Flow Metab. 2015;35:8.
Gonçalves J , Leitão RA , Higuera-Matas A , et al. Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown. Brain Behav Immun. 2017;62:306-317.
Rosas-Hernandez H , Cuevas E , Lantz SM , et al. Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. Neurosci Lett. 2016;629:125-130.
Abdul Muneer PM , Alikunju S , Szlachetka AM , Murrin LC , Haorah J . Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener. 2011;6:23.
Dang DK , Shin EJ , Kim DJ , et al. Ginsenoside re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated kappa-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor. J Neuroinflammation. 2018;15:1.
Mathema VB , Koh YS , Thakuri BC , Sillanpaa M . Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities. Inflammation. 2012;35:2.
Li X , Zhang Y , Wang Y , et al. The mechanisms of traditional Chinese medicine underlying the prevention and treatment of Parkinson's disease. Front Pharmacol. 2017;8:634.
Sobota R , Szwed M , Kasza A , Bugno M , Kordula T . Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family. Biochem Biophys Res Commun. 2000;267:329-333.
Coelho-Santos V , Gonçalves J , Fontes-Ribeiro C , Silva AP . Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway. J Neuroinflammation. 2012;9:103.
Dong L , Qiao H , Zhang X , et al. Parthenolide is neuroprotective in rat experimental stroke model: downregulating NF-kappaB, phospho-p38MAPK, and caspase-1 and ameliorating BBB permeability. Mediators Inflamm. 2013;2013:370804.
Khare P , Datusalia AK , Sharma SS . Parthenolide, an NF-kappaB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model. Neuromolecular Med. 2017;19:1.
Simera I , Moher D , Hoey J , Schulz KF , Altman DG . A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40:35-53.
de Aquino CC , Leitão RA , Oliveira AL , et al. Effect of hypoproteic and high-fat diets on hippocampal blood-brain barrier permeability and oxidative stress. Front Nutr. 2019;5:131.
Loftis JM , Choi D , Hoffman W , Huckans MS . Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res. 2011;20:1.
Martins T , Baptista S , Gonçalves J , et al. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 2011;1411:28-40.
Gonçalves J , Leitão RA , Higuera-Matas A , et al. Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown. Brain Behav Immun. 2017;62:306-317.
Beauquis J , Pavía P , Pomilio C , et al. Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease. Exp Neurol. 2013;239:28-37.
Eide PK , Eidsvaag VA , Nagelhus EA , Hansson H-A . Cortical astrogliosis and increased perivascular aquaporin-4 in idiopathic intracranial hypertension. Brain Res. 2016;1644:161-175.
Snider SE , Hendrick ES , Beardsley PM . Glial cell modulators attenuate methamphetamine self-administration in the rat. Eur J Pharmacol. 2013;701:1.
Rajkowska G , Hughes J , Stockmeier CA , Javier M-H , Maciag D . Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder. Biol Psychiatry. 2013;73:7.
Rummel C , Gerstberger R , Roth J , Hübschle T . Parthenolide attenuates LPS-induced fever, circulating cytokines and markers of brain inflammation in rats. Cytokine. 2011;56:739-748.
Williams B , Lees F , Tsangari H , Hutchinson MR , Perilli E , Crotti TN . Assessing the effects of parthenolide on inflammation, bone loss, and glial cells within a collagen antibody-induced arthritis mouse model. Mediators Inflamm. 2020;2020:6245798.
Wang JA , Tong ML , Zhao B , Zhu G , Xi DH , Yang JP . Parthenolide ameliorates intracerebral hemorrhage-induced brain injury in rats. Phytother Res. 2020;34:153-160.
Ohnishi M , Monda A , Takemoto R , et al. High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction. Neurochem Int. 2014;75:32-38.
Agatonovic-Kustrin S , Morton DW . The current and potential therapeutic uses of parthenolide. In: Rahman A-U , ed. Studies in Natural Products Chemistry. Vol 58, Chapter 3. Academic Press-Elsevier; 2018:61-91.
Kimbrough IF , Robel S , Roberson ED , Sontheimer H . Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease. Brain. 2015;138:2.
Kim JE , Ryu HJ , Choi SY , Kang TC . Tumor necrosis factor-alpha-mediated threonine 435 phosphorylation of p65 nuclear factor-kappaB subunit in endothelial cells induces vasogenic edema and neutrophil infiltration in the rat piriform cortex following status epilepticus. J Neuroinflammation. 2012;9:6.
Hosomi N , Ban CR , Naya T , et al. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:8.
Yan Y , Nitta A , Koseki T , Yamada K , Nabeshima T . Dissociable role of tumor necrosis factor alpha gene deletion in methamphetamine self-administration and cue-induced relapsing behavior in mice. Psychopharmacology. 2012;221:3.
Montgomery SL , Bowers WJ . Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol. 2012;7:1.
Alexander JJ , Jacob A , Cunningham P , Hensley L , Quigg RJ . TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008;52:3.
Yatsushige H , Calvert JW , Cahill J , Zhang JH . Limited role of inducible nitric oxide synthase in blood-brain barrier function after experimental subarachnoid hemorrhage. J Neurotrauma. 2006;23:12.
Fukuda K , Hibiya Y , Mutoh M , et al. Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Biochem Pharmacol. 2000;60:4.
Dietrich JB , Zaepfel M , Kuchler-Bopp S . Expression of intercellular adhesion molecule-1 in C6 glioma cells is up-regulated by thyroid hormone. NeuroReport. 2000;11:11.
Ichiki T , Jougasaki M , Setoguchi M , et al. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. Am J Physiol Heart Circ Physiol. 2008;294:2.